10.1002/anie.202006661
Angewandte Chemie International Edition
COMMUNICATION
[2]
a) V. K. Tiwari, B. B. Mishra, K. B. Mishra, N. Mishra, A. S. Singh, X.
Chen, Chem. Rev. 2016, 116, 3086-3240; b) Kiessling, L. L., Bioorg. Med.
Chem. 2018, 26, 5229-5238; c) R. T. Larson, A. Samant, J. Chen, W.
Lee, M. A. Bohn, D. M. Ohlmann, S. J. Zuend, F. D. Toste, J. Am. Chem.
Soc. 2017, 139, 14001-14004; d) J. Choutka, R. Pohl, K. Parkan, ACS
Omega 2018, 3, 7875-7887; e) V. Dimakos, M. S. Taylor, Chem. Rev.
2018, 118, 11457-11517; f) Y. Wang, H. M. Carder, A. E. Wendlandt,
Nature 2020, 578, 403-408.
[9]
a) J. B. Hochalter, Y. Zhong, S. Han, S. G. Carmella, S. S. Hecht, Chem.
Res. Toxicol. 2011, 24, 262-268; b) M. Wei, Z. Li, T. Li, B. Wu, Y. Liu, J.
Qu, X. Li, L. Li, L. Cai, P. G. Wang, ACS Catal. 2015, 5, 4060-4065.
[10] K. R. Prasad, A. Chandrakumar, Synthesis 2006, 13, 2159-2166.
[11] a) W. S. Knowles, Angew. Chem. Int. Ed. 2002, 41, 1998-2007; Angew.
Chem. 2002, 114, 2096-2107; b) R. Noyori, Adv. Synth. & Catal. 2003,
345,15-32; c) J.-P. Genet, Acc. Chem. Res. 2003, 36, 908-918; d) A. M.
Palmer, A. Zanotti-Gerosa, Curr. Opin. Drug Discovery Dev. 2010, 13,
698-716; e) D. J. Ager, A. H. M. de Vries, J. G. de Vries, Chem. Soc. Rev.
2012, 41, 3340-3380; f) J. Magano, J. R. Dunetz, Org. Process Res. Dev.
2012, 16, 1156-1184; g) C. S. G. Seo, R. H. Morris, Organometallics
2019, 38, 47-65.
[3]
a) A. B. Northrup, D. W. C. MacMillan, Science 2004, 305, 1752-1755;
b) O. Arjona, A. M. Gómez, J. C. López, J. Plumet, Chem. Rev. 2007,
107, 1919-2036; c) A. Bernardi, P. Cheshev, Chem.-Eur. J. 2008, 14,
7434-7441; d) Y.-Q. Fu, Y.-J. An, J.-C. Tao, Chin. J. Org. Chem. 2008,
28, 44-51; e) A. Kato, E. Hayashi, S. Miyauchi, I. Adachi, T. Imahori, Y.
Natori, Y. Yoshimura, R. J. Nash, H. Shimaoka, I. Nakagome, J. Koseki,
S. Hirono, H. Takahata, J. Med. Chem. 2012, 55, 10347-10362; f) ꢁ.
Canales, ꢁ. Mallagaray, M. ꢁ. Berbís, A.Navarro-Vázquez, G.
Domínguez, F. J. Caꢂada, S. Andrꢀ, H.-J. Gabius, J. Pꢀrez-Castells, J.
Jimꢀnez-Barbero, J. Am. Chem. Soc. 2014, 136, 8011-8017; g) K. L.
Hudson, G. J. Bartlett, R. C. Diehl, J. Agirre, T. Gallagher,L. L. Kiessling,
D. N. Woolfson, J. Am. Chem. Soc. 2015, 137, 15152-15160; h) K.
Chung, R. M. Waymouth, ACS Catal. 2016, 6, 4653-4659; i) Y. Yang, B.
Yu, Chem. Rev. 2017, 117, 12281-12356.
[12] P.-G. Echeverria, T. Ayad, P. Phansavath, V. Ratovelomanana-Vidal,
Synthesis 2016, 48, 2523-2539.
[13] P. Dupau, R. Epple, A. A. Thomas, V. V. Fokin, K. B. Sharpless, Adv.
Synth. & Catal. 2002, 344, 421-433.
[14] a) W. Wu, S. Liu, M. Duan, X. Tan, C. Chen, Y. Xie, Y. Lan, X.-Q. Dong,
X. Zhang, Org. Lett. 2016, 18, 2938-2941; b) Y. Hu, W. Wu, X.-Q. Dong,
X. Zhang, Org. Chem. Front. 2017, 4, 1499-1502; c) W. Wu, C. You, C.
Yin, Y. Liu, X.-Q. Dong, X. Zhang, Org. Lett. 2017, 19, 2548-2551; d) W.
Wu, Y. Xie, P. Li, X. Li, Y. Liu, X.-Q. Dong, X. Zhang, Org. Chem. Front.
2017, 4, 555-559; e) S. Wang, Y. Yu, J. Wen, X. Zhang, Synlett 2018, 29,
2203-2207. f) C. Yin, W. Wu, Y. Hu, X. Tan, C. You, Y. Liu, Z. Chen, X.-
Q. Dong, X. Zhang, Adv. Synth. & Catal. 2018, 360, 2119-2124.
[15] CCDC 2006347 ((±)-1a), 1996168 ((-)-1a) and 1996169 (3a) contain the
supplementary crystallographic data for this paper. Selected data is also
included in the Supporting Information.
[4]
a) S. A. W. Gruner, E. Locardi, E. Lohof, H. Kessler, Chem. Rev. 2002,
102, 491-514; b) R. S. Babu, G. A. O'Doherty, J. Am. Chem. Soc. 2003,
125, 12406-12407; c) R. S. Babu, M. Zhou, G. A. O'Doherty, J. Am.
Chem. Soc. 2004, 126, 3428-3429; d) Md. M. Ahmed, G. A. O'Doherty,
J. Org. Chem. 2005, 70, 10576-10578; e) B. Ernst, J. L. Magnani, Nat.
Rev. Drug Discov. 2009, 8, 661-677; f) I. Dragutan, V. Dragutan, A.
Demonceau, RSC Adv. 2012, 2, 719-736; g) J. Zhang, C. Xing, B. Tiwari,
Y. R. Chi, J. Am. Chem. Soc. 2013, 135, 8113-8116; h) E. Lenci, G.
Menchi, A. Guarna, A. Trabocchi, J. Org. Chem. 2015, 80, 2182-2191.
a) H. Zhang, H.-B. Liu, J.-M. Yue, Chem. Rev. 2014, 114, 883-898; b) B.
M. Trost, J. D. Knopf, C. S. Brindle, Chem. Rev. 2016, 116, 15035-15088.
C. Y. Park, B. M. Kim, K. B. Sharpless, Tetrahedron Lett. 1991, 32, 1003-
1006.
[16] The absolute configurations of C3 and C4 of triol 5 should be kept the
same with the C1 and C2 of 1,2,3,4-tetraol 3a. The diastereomers are
anti-anti-5 and anti-syn-5. The dr of compound 5 is the molar ratio of the
two diastereomers (major : minor), and the dr value was determined by
1H NMR analysis of crude reaction mixture. Because the two
diastereomers are easy to epimerize at C2 stereocenter, the dr value
(4:1) does not mean the real diastereoselectivity, only reflects the molar
ratio of the diastereomers at the time of NMR data acquisition.
[5]
[6]
[7]
[8]
T. V. Robinson, D. K. Taylor, E. R. T. Tiekink, J. Org. Chem. 2006, 71,
7236-7244.
a) L. L. Adduci, M. P. McLaughlin, T. A. Bender, J. J. Becker, M. R.
Gagné, Angew. Chem. Int. Ed. 2014, 53, 1646-1649; Angew. Chem.
2014, 125, 1672-1675; b) L. L. Adduci, T. A. Bender, J. A. Dabrowski, M.
R. Gagné, Nature Chem. 2015, 7, 576-581; c) J. M. Lowe, Y. Seo, M. R.
Gagnꢀ, ACS Catal. 2018, 8, 8192-8198.
This article is protected by copyright. All rights reserved.